-+ 0.00%
-+ 0.00%
-+ 0.00%

CMG Pharmaceutical buys back KRW 15.49 billion of 8th convertible bonds before maturity

PUBT·10/12/2026 07:56:30
Listen to the news
CMG Pharmaceutical buys back KRW 15.49 billion of 8th convertible bonds before maturity
  • CMG Pharmaceutical repurchased KRW 15.49 billion of its 8th privately placed convertible bonds before maturity.
  • Repurchase followed bondholders’ put option; bonds carried a conversion price of KRW 17,770 per share.
  • The acquired principal amount was KRW 14.97 billion; outstanding principal falls to KRW 7.5 billion.
  • Payment date set for Oct. 12, 2026; bonds to be cancelled via Korea Securities Depository.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CMG Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261012900559), on October 12, 2026, and is solely responsible for the information contained therein.